In summary, the findings so far discussed point each other to the role of androgen/AR pathway impairment in skeletal muscle wasting, sarcopenia progression, obesity, insulin-resistance, inflammation and immuno-senescence. This evidence concerns the gene AR and obesity due to melanocortin 4 receptor deficiency.